On October 13, five major cryptocurrency transfers totaling $489.6 million were recorded within a three-hour period. The largest was a $134.7 million USDC transfer from the USDC Treasury to an unknown wallet. Overall, $210.3 million moved out of exchanges while $169.3 million moved into exchanges, involving assets like USDC, USDT, and ETH. These movements are closely watched by market participants as potential indicators of selling or holding, though wallet transfers alone do not confirm intent or next actions.
The recent $134.7 million USDC transfer is part of a total $489.6 million in cryptocurrency movements recorded on October 13. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 14, 2026 01:03 WIB: out of 50 major cryptocurrencies, 13 rose and 36 fell. Notable movers include THETA with a 1-day change of -4.21% and typical hold time of 77 days, NEO down 4.13% with 96 days hold time, and VET down 3.96% with a 148-day hold time and 90% buy order activity.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
